287 related articles for article (PubMed ID: 33832921)
1. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
[TBL] [Abstract][Full Text] [Related]
2. The landscape of somatic mutations in Down syndrome-related myeloid disorders.
Yoshida K; Toki T; Okuno Y; Kanezaki R; Shiraishi Y; Sato-Otsubo A; Sanada M; Park MJ; Terui K; Suzuki H; Kon A; Nagata Y; Sato Y; Wang R; Shiba N; Chiba K; Tanaka H; Hama A; Muramatsu H; Hasegawa D; Nakamura K; Kanegane H; Tsukamoto K; Adachi S; Kawakami K; Kato K; Nishimura R; Izraeli S; Hayashi Y; Miyano S; Kojima S; Ito E; Ogawa S
Nat Genet; 2013 Nov; 45(11):1293-9. PubMed ID: 24056718
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
4. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract][Full Text] [Related]
5. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
[TBL] [Abstract][Full Text] [Related]
6. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
[TBL] [Abstract][Full Text] [Related]
7. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
8. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
[TBL] [Abstract][Full Text] [Related]
9. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia.
Hama A; Muramatsu H; Makishima H; Sugimoto Y; Szpurka H; Jasek M; O'Keefe C; Takahashi Y; Sakaguchi H; Doisaki S; Shimada A; Watanabe N; Kato K; Kiyoi H; Naoe T; Kojima S; Maciejewski JP
Br J Haematol; 2012 Feb; 156(3):316-25. PubMed ID: 22122069
[TBL] [Abstract][Full Text] [Related]
10. Natural history of GATA1 mutations in Down syndrome.
Ahmed M; Sternberg A; Hall G; Thomas A; Smith O; O'Marcaigh A; Wynn R; Stevens R; Addison M; King D; Stewart B; Gibson B; Roberts I; Vyas P
Blood; 2004 Apr; 103(7):2480-9. PubMed ID: 14656875
[TBL] [Abstract][Full Text] [Related]
11. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
[TBL] [Abstract][Full Text] [Related]
13. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
14. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC; Ge Y; Taub JW
J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
[TBL] [Abstract][Full Text] [Related]
17. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
18. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
[TBL] [Abstract][Full Text] [Related]
19. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL.
Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE
Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
